A sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC/MS/MS

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):329-34. doi: 10.1016/j.jchromb.2006.10.053. Epub 2006 Nov 27.

Abstract

A protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method has been developed and validated for the simultaneous determination of valganciclovir and its active metabolite ganciclovir in human plasma. The solvent system also served as a protein precipitation reagent. The chromatographic separation was achieved on an Aquasil C18 column (50 mm x 2.1mm, 5 microm). A linear gradient mobile phase between 0.02% formic acid and methanol was used. Detection was by positive ion electrospray tandem mass spectrometry on a Sciex API3000. The standard curves, which ranged from 4 to 512 ng/mL for valganciclovir and from 0.1 to 12.8 microg/mL for ganciclovir, were fitted to a 1/x weighted quadratic regression model. The method was proved to be accurate, specific and sensitive enough and was successfully applied to a pharmacokinetic study.

MeSH terms

  • Antiviral Agents / blood
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacokinetics
  • Chromatography, Liquid / methods*
  • Drug Stability
  • Ganciclovir / analogs & derivatives*
  • Ganciclovir / blood*
  • Ganciclovir / chemistry
  • Ganciclovir / pharmacokinetics
  • Humans
  • Molecular Structure
  • Reproducibility of Results
  • Tandem Mass Spectrometry / methods*
  • Valganciclovir

Substances

  • Antiviral Agents
  • Valganciclovir
  • Ganciclovir